Based on the key indicators obtained from National Research's historical financial statements, National Research Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December. At present, National Research's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Total Liabilities is expected to grow to about 77.2 M, whereas Total Assets are forecasted to decline to about 80.7 M. Key indicators impacting National Research's financial strength include:
The essential information of the day-to-day investment outlook for National Research includes many different criteria found on its balance sheet. An individual investor should monitor National Research's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in National Research.
Net Income
32.52 Million
National
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Payables Turnover
Sales General And Administrative To Revenue
Average Inventory
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Average Receivables
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Dividends Paid
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Sale Purchase Of Stock
Stock Based Compensation
Change To Inventory
Change To Liabilities
Change To Account Receivables
Total Cashflows From Investing Activities
Other Cashflows From Investing Activities
Change Receivables
Net Borrowings
Exchange Rate Changes
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Netincome
Investments
Change To Operating Activities
Total Assets
Total Stockholder Equity
Other Assets
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Other Stockholder Equity
Total Liab
Other Current Liab
Total Current Liabilities
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Non Current Liabilities Total
Other Current Assets
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Short Long Term Debt Total
Intangible Assets
Short Term Debt
Other Liab
Long Term Debt
Common Stock Total Equity
Inventory
Treasury Stock
Common Stock
Property Plant Equipment
Current Deferred Revenue
Good Will
Retained Earnings Total Equity
Deferred Long Term Liab
Net Tangible Assets
Long Term Debt Total
Capital Surpluse
Capital Lease Obligations
Short Long Term Debt
Non Current Liabilities Other
Net Invested Capital
Net Working Capital
Depreciation And Amortization
Interest Expense
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Selling General Administrative
Net Income Applicable To Common Shares
Net Income From Continuing Ops
Non Operating Income Net Other
Tax Provision
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past National Research Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of National Research's financial statements are interrelated, with each one affecting the others. For example, an increase in National Research's assets may result in an increase in income on the income statement.
Please note, the presentation of National Research's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, National Research's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of National Research's management manipulating its earnings.
National Research Stock Summary
National Research competes with Omega Flex, NI Holdings, PC Connection, and Northrim BanCorp. National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska. National Research operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 511 people.
Comparative valuation techniques use various fundamental indicators to help in determining National Research's current stock value. Our valuation model uses many indicators to compare National Research value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across National Research competition to find correlations between indicators driving National Research's intrinsic value. More Info.
National Research Corp is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.32 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for National Research Corp is roughly 3.16 . At present, National Research's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the National Research's earnings, one of the primary drivers of an investment's value.
National Research's Earnings Breakdown by Geography
National Research Corp Systematic Risk
National Research's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. National Research volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on National Research Corp correlated with the market. If Beta is less than 0 National Research generally moves in the opposite direction as compared to the market. If National Research Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one National Research Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of National Research is generally in the same direction as the market. If Beta > 1 National Research moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in National Research Stock are looking for potential investment opportunities by analyzing not only static indicators but also various National Research's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of National Research growth as a starting point in their analysis.
Price Earnings To Growth Ratio
(19.06)
At present, National Research's Price Earnings To Growth Ratio is projected to decrease significantly based on the last few years of reporting.
National Research November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of National Research help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of National Research Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of National Research Corp based on widely used predictive technical indicators. In general, we focus on analyzing National Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build National Research's daily price indicators and compare them against related drivers.
When running National Research's price analysis, check to measure National Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Research is operating at the current time. Most of National Research's value examination focuses on studying past and present price action to predict the probability of National Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Research's price. Additionally, you may evaluate how the addition of National Research to your portfolios can decrease your overall portfolio volatility.
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance